Written question asked by Andrew Western (Labour) on Monday, 27 March 2023, in the House of Commons. It was due for an answer on Wednesday, 29 March 2023. It was answered by Will Quince (Conservative) on Thursday, 13 April 2023 on behalf of the Department of Health and Social Care.
Isotretinoin: Reviews
- Question
-
To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency review into the use of Roaccutane will be (a) concluded and (b) published.
- Answer
-
An Expert Working Group has reviewed the available evidence relating to isotretinoin (Roaccutane). We expect the report to be published shortly.
Secondary information
- Type
- Written question
- Reference
- 174523
- Session
- 2022-23
- Subjects
- Reviews Isotretinoin Medicines and Healthcare products Regulatory Agency
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-04-13 11:16:29 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/174523
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/174523
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/174523